Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial-Reference-Cited by-同舟云学术

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

Published:2005-04 Issue:9470 Volume:365 Page:1552-1560
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Decramer Marc,Rutten-van Mölken Maureen,Dekhuijzen PN Richard,Troosters Thierry,van Herwaarden Cees,Pellegrino Riccardo,van Schayck CP Onno,Olivieri Dario,Del Donno Mario,De Backer Wilfried,Lankhorst Ida,Ardia Alfredo

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Oxidative stress in chronic obstructive pulmonary disease;Repine;Am J Respir Crit Care Med,1997

2. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease;MacNee;Am J Respir Crit Care Med,1999

3. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease;Dekhuijzen;Am J Respir Crit Care Med,1996

4. Exhaled carbon monoxide and nitric oxide in COPD;Montuschi;Chest,2001

5. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease;Paredi;Am J Respir Crit Care Med,2000

Cited by 549 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria in inflammatory lung diseases;Frontiers in Pharmacology;2024-08-20

2. Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway;International Journal of Chronic Obstructive Pulmonary Disease;2024-08

3. Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective;Journal of Clinical Medicine;2024-07-15

4. Effects of acetylcysteine on micro-inflammation and pulmonary ventilation in chronic obstructive pulmonary disease exacerbation;World Journal of Clinical Cases;2024-06-26

5. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses;Archivos de Bronconeumología;2024-05